BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback